Grand Venture 'well-poised' to gain across segments: DBS
Add BT as a preferred source
Singapore
GRAND Venture Technology (GVT) is likely "well-poised" to gain from the positive industry outlook on all 3 of its segments, which includes the semiconductor, life sciences, and electronics and medical segments, said DBS Group Research.
The research team on Thursday (Apr 14) initiated coverage on the precision manufacturing company with a "buy" call and target price of S$1.50, as it assumes revenue will grow by 25 per cent in FY2022 and 22.5 per cent in FY2023.
TRENDING NOW
Employers want AI-fluent employees. Hiring them is the challenge
Cat A hits record S$129,000 as COE rises across the board
E-commerce job cuts signal S-E Asia’s shift from scaling to deeper user engagement
Changes to EV incentives, uncertainty over COE framework drive Category A to a new high in ‘re-run of 2025 mania’
